Bhutan vs Canada: Proportion of isolates with decreased susceptibility or resistance
Bhutan
1
in 2020
Canada
1.4
in 2020
Bhutan rank
8th
Canada rank
7th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- Canada
How they compare
Canada currently reports 1.4 against 1 in Bhutan, a difference of 0.4.
That makes Canada's figure about 1.4 times Bhutan's.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was Canada ahead.
Bhutan ranks 8th and Canada ranks 7th of 52 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 3.09 | 3.09 | Canada |
| 2010s | 1.74 | 3.28 | 1.55 | Canada |
| 2020s | 1 | 1.4 | 0.4 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or Canada?
- Canada, at 1.4 against 1 in Bhutan as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and Canada?
- 0.4, with Canada ahead.
- How many years of comparable data are there for Bhutan and Canada?
- 9 years are reported by both, from 2009 to 2020.
- How do Bhutan and Canada rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 8th and Canada ranks 7th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.